These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20105179)

  • 1. Effects of peroxisome proliferator-activated receptor gamma agonists on Na+ transport and activity of the kinase SGK1 in epithelial cells from lung and kidney.
    Wilson SM; Mansley MK; Getty J; Husband EM; Inglis SK; Hansen MK
    Br J Pharmacol; 2010 Feb; 159(3):678-88. PubMed ID: 20105179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARγ-induced stimulation of amiloride-sensitive sodium current in renal collecting duct principal cells is serum and insulin dependent.
    Chraïbi A; Renauld S
    Cell Physiol Biochem; 2014; 33(3):581-93. PubMed ID: 24603133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gamma antagonists decrease Na+ transport via the epithelial Na+ channel.
    Pavlov TS; Levchenko V; Karpushev AV; Vandewalle A; Staruschenko A
    Mol Pharmacol; 2009 Dec; 76(6):1333-40. PubMed ID: 19752200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of epithelial Na+ absorption induced by inhibition of the kinases TORC1 and TORC2.
    Mansley MK; Wilson SM
    Br J Pharmacol; 2010 Dec; 161(8):1778-92. PubMed ID: 20735411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone.
    Artunc F; Sandulache D; Nasir O; Boini KM; Friedrich B; Beier N; Dicks E; Pötzsch S; Klingel K; Amann K; Blazer-Yost BL; Scholz W; Risler T; Kuhl D; Lang F
    Pflugers Arch; 2008 May; 456(2):425-36. PubMed ID: 18172605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of ENaC activity by rosiglitazone is PPARγ-dependent and correlates with SGK1 expression increase.
    Renauld S; Tremblay K; Ait-Benichou S; Simoneau-Roy M; Garneau H; Staub O; Chraïbi A
    J Membr Biol; 2010 Aug; 236(3):259-70. PubMed ID: 20740360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone promotes ENaC-mediated alveolar fluid clearance in acute lung injury through the PPARγ/SGK1 signaling pathway.
    He J; Qi D; Tang XM; Deng W; Deng XY; Zhao Y; Wang DX
    Cell Mol Biol Lett; 2019; 24():35. PubMed ID: 31160894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nominally selective inhibitors of the kinases PI3K, SGK1 and PKB on the insulin-dependent control of epithelial Na+ absorption.
    Mansley MK; Wilson SM
    Br J Pharmacol; 2010 Oct; 161(3):571-88. PubMed ID: 20880397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-γ agonists repress epithelial sodium channel expression in the kidney.
    Borsting E; Cheng VP; Glass CK; Vallon V; Cunard R
    Am J Physiol Renal Physiol; 2012 Mar; 302(5):F540-51. PubMed ID: 22169011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique properties of coactivator recruitment caused by differential binding of FK614, an anti-diabetic agent, to peroxisome proliferator-activated receptor gamma.
    Fujimura T; Sakuma H; Ohkubo-Suzuki A; Aramori I; Mutoh S
    Biol Pharm Bull; 2006 Mar; 29(3):423-9. PubMed ID: 16508139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone and insulin activate serum and glucocorticoid-inducible kinase 1 (SGK1) via different molecular mechanisms in cortical collecting duct cells.
    Mansley MK; Watt GB; Francis SL; Walker DJ; Land SC; Bailey MA; Wilson SM
    Physiol Rep; 2016 May; 4(10):. PubMed ID: 27225626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs.
    Schinner S; Krätzner R; Baun D; Dickel C; Blume R; Oetjen E
    Br J Pharmacol; 2009 Jul; 157(5):736-45. PubMed ID: 19338578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone induced gastric acid secretion.
    Rotte A; Mack AF; Bhandaru M; Kempe DS; Beier N; Scholz W; Dicks E; Pötzsch S; Kuhl D; Lang F
    Cell Physiol Biochem; 2009; 24(3-4):193-200. PubMed ID: 19710534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation.
    Liu C; Zhang Y; Yuan L; Fu L; Mei C
    Mol Med Rep; 2013 Sep; 8(3):861-4. PubMed ID: 23864113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
    Sommer M; Wolf G
    Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
    Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
    J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions among peroxisome proliferator activated receptor-gamma, insulin signaling pathways, and steroidogenic acute regulatory protein in human ovarian cells.
    Seto-Young D; Avtanski D; Strizhevsky M; Parikh G; Patel P; Kaplun J; Holcomb K; Rosenwaks Z; Poretsky L
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2232-9. PubMed ID: 17374711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARgamma agonists do not directly enhance basal or insulin-stimulated Na(+) transport via the epithelial Na(+) channel.
    Nofziger C; Chen L; Shane MA; Smith CD; Brown KK; Blazer-Yost BL
    Pflugers Arch; 2005 Dec; 451(3):445-53. PubMed ID: 16170524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone-regulated transepithelial Na+ transport in mammalian CCD cells requires SGK1 expression.
    Helms MN; Fejes-Toth G; Naray-Fejes-Toth A
    Am J Physiol Renal Physiol; 2003 Mar; 284(3):F480-7. PubMed ID: 12429555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.